Hong Kong’s stock exchange welcomed its newest stock with a virtual gong-banging ceremony as the Asian financial hub seeks to keep business going amid a partial lockdown that has now lasted for almost two months to contain the spread of the coronavirus.
InnoCare Pharma Ltd, a Chinese mainland biotech firm, on Monday became the first IPO to debut via a virtual listing ceremony at HKEX
InnoCare Pharma Ltd, a Chinese mainland biotech firm, on Monday became the first initial public offering to debut via a virtual listing ceremony at Hong Kong Exchanges & Clearing Ltd, following similar events in both Shanghai and Shenzhen on the mainland. The shares rose 11.2 percent to HK$9.95 as of 11:30 am, even as the benchmark Hang Seng index slid almost 3.3 percent.
InnoCare, which also moved its presentations to investors online ahead of the IPO, successfully priced a US$288 million transaction earlier this month at the top of its range amid one of the worst market routs in more than three decades. Normally a festive affair, a listing usually attracts hundreds of people including executives, bankers and lawyers as well as caterers.
Hong Kong, which has seen a recent spike in coronavirus cases, has restricted travel into the city, forcing most visitors to self-quarantine for 14 days. The virus has infected more than 300,000 people globally and killed almost 15,000, and is set to trigger a steep drop in economic activity across the world.
The Shanghai Stock Exchange arranged a virtual listing starting Feb 23, starting off with a company from Hubei, the heart of virus outbreak. Shenzhen Stock Exchange also welcomed its first “cloud listing” on March 6.
Copyright 1995 - 2021. All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily. Without written authorization from China Daily, such content shall not be republished or used in any form.
HONG KONG NEWS